Vidvan Image

Dr Dhanlaxmi Shetty

vidwan id: 171452
Female

Scientific Officer E, Clinical Research Centre
Advanced Centre for Treatment, Research and Education in Cancer

Expertise

  • Cytology and Histology

Publications

Total Articles 42
Books 0
Proceedings 0

Publications

No publication activity to display at the moment.

Scopus

Citations 329
h-index 10

CrossRef

CrossRef Icon
Citations 393
h-index 11
Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Bio

Cytogenetics

Personal Details

  • Female
  • Scientific Officer E , Advanced Centre for Treatment, Research and Education in Cancer
  • Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Plot No. 1& 2, Kharghar
PG Diploma
Other Institute 2013
Scientific Officer E Dec 2015 – Present
Advanced Centre for Treatment, Research and Education in Cancer | Clinical Research Centre

Related Profiles

Experts (21+)

View All
Abhishek

Mr Abhishek Agarwal

Assistant Professor

Preeti

Dr Preeti Sharma

Assistant Professor

Pavithra

Pavithra Velayutham

Assistant Professor

Mahaboob

Dr Mahaboob Basha

Physical Director

HIBA

HIBA -

Assistant Professor

Muskan

Dr Muskan Jain (PT)

Assistant Professor

Shalini

Ms Shalini Saini

Assistant Professor

Organisations (107+)

View All
Ashok

Dr Ashok Varma

Principal Investigator

Atanu

Dr Atanu Bhattacharjee

Assistant Professor

Asawari

Dr Asawari Patil

Associate Professor

Kiran

Dr Kiran Bendale

Scientific Officer C

Bhakti

Dr Bhakti Trivedi

Associate Professor

Nirmal Kumar

Dr Nirmal Kumar

Scientific Officer D

Anand

Mr Anand Patil

Scientific Officer C

Amol

Dr Amol Kothekar

Associate Professor

Co-Authors (20)

Amit

Dr Amit Dutt

Advanced Centre for Treatment, Research and Education in Cancer

Prashant

Dr Prashant Tembhare

Advanced Centre for Treatment, Research and Education in Cancer

Jayant

Dr Jayant Goda

Advanced Centre for Treatment, Research and Education in Cancer

Hemani

Ms Hemani Jain

Advanced Centre for Treatment, Research and Education in Cancer

Jyoti

Dr Jyoti Kode

Advanced Centre for Treatment, Research and Education in Cancer

Manju

Dr Manju Sengar

Advanced Centre for Treatment, Research and Education in Cancer

Navin

Dr Navin Khattry

Advanced Centre for Treatment, Research and Education in Cancer

Nikhil

Dr Nikhil Patkar

Advanced Centre for Treatment, Research and Education in Cancer

Subramanian

Dr Subramanian Ganesan

Advanced Centre for Treatment, Research and Education in Cancer

Pradnya

Dr Pradnya Kowtal

Advanced Centre for Treatment, Research and Education in Cancer

Purvi

Ms Purvi Mohanty

Advanced Centre for Treatment, Research and Education in Cancer

Sajid

Dr Sajid Qureshi

Advanced Centre for Treatment, Research and Education in Cancer

Shilpee

Dr Shilpee Dutt

Advanced Centre for Treatment, Research and Education in Cancer

Syed

Dr Syed Hasan

Advanced Centre for Treatment, Research and Education in Cancer

Sadhana

Sadhana Kannan

Advanced Centre for Treatment, Research and Education in Cancer

Sridhar

Dr Sridhar Epari

Advanced Centre for Treatment, Research and Education in Cancer

Swapnali

Swapnali Joshi

Advanced Centre for Treatment, Research and Education in Cancer

Vikram

Dr Vikram Gota

Advanced Centre for Treatment, Research and Education in Cancer

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-10<sup>6</sup> and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients

Open Access
Article
Authors: Tembhare P.R.;Subramanian PG P.G.;Ghogale S.;Chatterjee G.;Patkar N.V.;Gupta A.;Shukla R.;Badrinath Y.;Deshpande N.;Narula G.;Rodrigues P.;Girase K.;Dhaliwal D.;Prasad M.;Shetty D.;Banavali S.;Gujral S.

Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy

Open Access
Article
Authors: Bagal B.;Kumar R.;Gaur T.;Talreja V.;Bonda A.;Patkar N.;Shetty D.;Kowtal P.;Subramanian P.G.;Gupta S.;Sarin R.;Hasan S.K.

Utility of immunophenotypic measurable residual disease in adult acute myeloid leukemia-real-world context

Open Access
Article
Authors: Patkar N.;Kakirde C.;Bhanshe P.;Joshi S.;Chaudhary S.;Badrinath Y.;Ghoghale S.;Deshpande N.;Kadechkar S.;Chatterjee G.;Kannan S.;Shetty D.;Gokarn A.;Punatkar S.;Bonda A.;Nayak L.;Jain H.;Bagal B.;Menon H.;Sengar M.;Khizer S.H.;Khattry N.;Tembhare P.;Gujra

Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia (Oncotarget (2018) 9 (36613-36624) DOI: 10.18632/oncotarget.26400)

Open Access
Erratum
Authors: Patkar N.;Kodgule R.;Kakirde C.;Raval G.;Bhanshe P.;Joshi S.;Chaudhary S.;Badrinath Y.;Ghoghale S.;Kadechkar S.;Khizer S.H.;Kannan S.;Shetty D.;Gokarn A.;Punatkar S.;Jain H.;Bagal B.;Menon H.;Sengar M.;Khattry N.;Tembhare P.;Subramanian P.;Gujral S.

A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1

Open Access
Letter
Authors: Patkar N.;Shaikh A.F.;Kakirde C.;Nathany S.;Ramesh H.;Bhanshe P.;Joshi S.;Chaudhary S.;Kannan S.;Khizer S.H.;Chatterjee G.;Tembhare P.;Shetty D.;Gokarn A.;Punatkar S.;Bonda A.;Nayak L.;Jain H.;Khattry N.;Bagal B.;Sengar M.;Gujral S.;Subramanian P.

Molecular heterogeneity in acute promyelocytic leukemia - A single center experience from India

Open Access
Article
Authors: Rabade N.;Raval G.;Chaudhary S.;Subramanian P.G.;Kodgule R.;Joshi S.;Tembhare P.;Hasan S.K.;Jain H.;Sengar M.;Narula G.;Banavali S.;Kadam P.A.;Shetty D.;Gujral S.;Patkar N.

Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit

Open Access
Article
Authors: Khattry N.;Laskar S.;Sengar M.;Rangarajan V.;Shet T.;Subramanian P.;Epari S.;Bagal B.;Goda J.S.;Agarwal A.;Jain H.;Tembhare P.;Patkar N.;Khanna N.;Punatar S.;Gokarn A.;Shetty D.;Jain H.;Bonda A.;Gota V.;Hasan S.;Kode J.;Dutt S.;Kulkarni S.;Shetty N.;Sable

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia

Open Access
Article
Authors: Patkar N.;Kodgule R.;Kakirde C.;Raval G.;Bhanshe P.;Joshi S.;Chaudhary S.;Badrinath Y.;Ghoghale S.;Kadechkar S.;Khizer S.H.;Kannan S.;Shetty D.;Gokarn A.;Punatkar S.;Jain H.;Bagal B.;Menon H.;Sengar M.;Khattry N.;Tembhare P.;Subramanian P.;Gujral S.
25